Healthcare costs and utilization of diabetes-related complications in Taiwan

A claims database analysis

Ssu-Wei Cheng, Chin-Yuan Wang, Jin-Hua Chen, Yu Ko

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

To estimate the healthcare utilization and costs of major diabetes mellitus (DM)-related complications in Taiwan in the year of first occurrence and in subsequent years.This study is a retrospective claim database analysis using the longitudinal cohort of diabetes patients (LHDB) with 2012 as the base year. Occurrences of 8 DM-related complications of interest were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Annual healthcare costs and utilization of these DM-related complications in the LHDB cohorts of the years 2004 to 2009 were examined, and the generalized linear model was used to estimate annual total healthcare costs for each complication.DM patients with complications were more likely to have at least 1 emergency room (ER) visit and at least 1 hospitalization (both P < .001), and they also had more outpatient visits, higher hospitalization costs, higher outpatient costs, and higher ER costs (all P < .001) than those without. The mean annual total healthcare cost of the patients with DM-related complications was US $4189, whereas the mean annual cost of those patients without complication was $1424 (P < .001). The complications with the greatest event costs were amputation ($7877; 95% confidence interval [CI]: $6628-$9322) and fatal MI ($4067; 95% CI: $3001-$5396) while the complication with the greatest state costs was end-stage renal disease (ESRD) ($2228; 95% CI: $2155 to $2302).DM-related complications could significantly increase healthcare utilization and costs. The results of this study provide data that are useful for local economic evaluations of DM treatments.

Original languageEnglish
Pages (from-to)e11602
JournalMedicine
Volume97
Issue number31
DOIs
Publication statusPublished - Aug 2018

Fingerprint

Insurance Claim Review
Diabetes Complications
Taiwan
Health Care Costs
Diabetes Mellitus
Databases
Costs and Cost Analysis
International Classification of Diseases
Confidence Intervals
Hospital Emergency Service
Hospitalization
Outpatients
Amputation
Chronic Kidney Failure
Cost-Benefit Analysis
Linear Models

Keywords

  • Ambulatory Care/economics
  • Cost of Illness
  • Databases, Factual
  • Diabetes Complications/economics
  • Diabetes Mellitus/economics
  • Female
  • Health Care Costs/statistics & numerical data
  • Hospitalization/economics
  • Humans
  • Insurance Claim Review
  • Linear Models
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Patient Acceptance of Health Care/statistics & numerical data
  • Retrospective Studies
  • Taiwan

Cite this

Healthcare costs and utilization of diabetes-related complications in Taiwan : A claims database analysis. / Cheng, Ssu-Wei; Wang, Chin-Yuan; Chen, Jin-Hua; Ko, Yu.

In: Medicine, Vol. 97, No. 31, 08.2018, p. e11602.

Research output: Contribution to journalArticle

@article{90d4850aacd64a05aa629d5be2fd50b5,
title = "Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis",
abstract = "To estimate the healthcare utilization and costs of major diabetes mellitus (DM)-related complications in Taiwan in the year of first occurrence and in subsequent years.This study is a retrospective claim database analysis using the longitudinal cohort of diabetes patients (LHDB) with 2012 as the base year. Occurrences of 8 DM-related complications of interest were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Annual healthcare costs and utilization of these DM-related complications in the LHDB cohorts of the years 2004 to 2009 were examined, and the generalized linear model was used to estimate annual total healthcare costs for each complication.DM patients with complications were more likely to have at least 1 emergency room (ER) visit and at least 1 hospitalization (both P < .001), and they also had more outpatient visits, higher hospitalization costs, higher outpatient costs, and higher ER costs (all P < .001) than those without. The mean annual total healthcare cost of the patients with DM-related complications was US $4189, whereas the mean annual cost of those patients without complication was $1424 (P < .001). The complications with the greatest event costs were amputation ($7877; 95{\%} confidence interval [CI]: $6628-$9322) and fatal MI ($4067; 95{\%} CI: $3001-$5396) while the complication with the greatest state costs was end-stage renal disease (ESRD) ($2228; 95{\%} CI: $2155 to $2302).DM-related complications could significantly increase healthcare utilization and costs. The results of this study provide data that are useful for local economic evaluations of DM treatments.",
keywords = "Ambulatory Care/economics, Cost of Illness, Databases, Factual, Diabetes Complications/economics, Diabetes Mellitus/economics, Female, Health Care Costs/statistics & numerical data, Hospitalization/economics, Humans, Insurance Claim Review, Linear Models, Longitudinal Studies, Male, Middle Aged, Patient Acceptance of Health Care/statistics & numerical data, Retrospective Studies, Taiwan",
author = "Ssu-Wei Cheng and Chin-Yuan Wang and Jin-Hua Chen and Yu Ko",
year = "2018",
month = "8",
doi = "10.1097/MD.0000000000011602",
language = "English",
volume = "97",
pages = "e11602",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "31",

}

TY - JOUR

T1 - Healthcare costs and utilization of diabetes-related complications in Taiwan

T2 - A claims database analysis

AU - Cheng, Ssu-Wei

AU - Wang, Chin-Yuan

AU - Chen, Jin-Hua

AU - Ko, Yu

PY - 2018/8

Y1 - 2018/8

N2 - To estimate the healthcare utilization and costs of major diabetes mellitus (DM)-related complications in Taiwan in the year of first occurrence and in subsequent years.This study is a retrospective claim database analysis using the longitudinal cohort of diabetes patients (LHDB) with 2012 as the base year. Occurrences of 8 DM-related complications of interest were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Annual healthcare costs and utilization of these DM-related complications in the LHDB cohorts of the years 2004 to 2009 were examined, and the generalized linear model was used to estimate annual total healthcare costs for each complication.DM patients with complications were more likely to have at least 1 emergency room (ER) visit and at least 1 hospitalization (both P < .001), and they also had more outpatient visits, higher hospitalization costs, higher outpatient costs, and higher ER costs (all P < .001) than those without. The mean annual total healthcare cost of the patients with DM-related complications was US $4189, whereas the mean annual cost of those patients without complication was $1424 (P < .001). The complications with the greatest event costs were amputation ($7877; 95% confidence interval [CI]: $6628-$9322) and fatal MI ($4067; 95% CI: $3001-$5396) while the complication with the greatest state costs was end-stage renal disease (ESRD) ($2228; 95% CI: $2155 to $2302).DM-related complications could significantly increase healthcare utilization and costs. The results of this study provide data that are useful for local economic evaluations of DM treatments.

AB - To estimate the healthcare utilization and costs of major diabetes mellitus (DM)-related complications in Taiwan in the year of first occurrence and in subsequent years.This study is a retrospective claim database analysis using the longitudinal cohort of diabetes patients (LHDB) with 2012 as the base year. Occurrences of 8 DM-related complications of interest were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Annual healthcare costs and utilization of these DM-related complications in the LHDB cohorts of the years 2004 to 2009 were examined, and the generalized linear model was used to estimate annual total healthcare costs for each complication.DM patients with complications were more likely to have at least 1 emergency room (ER) visit and at least 1 hospitalization (both P < .001), and they also had more outpatient visits, higher hospitalization costs, higher outpatient costs, and higher ER costs (all P < .001) than those without. The mean annual total healthcare cost of the patients with DM-related complications was US $4189, whereas the mean annual cost of those patients without complication was $1424 (P < .001). The complications with the greatest event costs were amputation ($7877; 95% confidence interval [CI]: $6628-$9322) and fatal MI ($4067; 95% CI: $3001-$5396) while the complication with the greatest state costs was end-stage renal disease (ESRD) ($2228; 95% CI: $2155 to $2302).DM-related complications could significantly increase healthcare utilization and costs. The results of this study provide data that are useful for local economic evaluations of DM treatments.

KW - Ambulatory Care/economics

KW - Cost of Illness

KW - Databases, Factual

KW - Diabetes Complications/economics

KW - Diabetes Mellitus/economics

KW - Female

KW - Health Care Costs/statistics & numerical data

KW - Hospitalization/economics

KW - Humans

KW - Insurance Claim Review

KW - Linear Models

KW - Longitudinal Studies

KW - Male

KW - Middle Aged

KW - Patient Acceptance of Health Care/statistics & numerical data

KW - Retrospective Studies

KW - Taiwan

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85051179802&origin=resultslist&sort=plf-f&src=s&st1=Healthcare+costs+and+utilization+of+diabetes-related+complications+in+Taiwan%3a+A+claims+database+analysis&st2=&sid=1c7d08cbc79d861201dfdd64d098519a&sot=b&sdt=b&sl=119&s=TITLE-ABS-KEY%28Healthcare+costs+and+utilization+of+diabetes-related+complications+in+Taiwan%3a+A+claims+database+analysis%29&relpos=0&citeCnt=0&searchTerm=

U2 - 10.1097/MD.0000000000011602

DO - 10.1097/MD.0000000000011602

M3 - Article

VL - 97

SP - e11602

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 31

ER -